Skip to main content

Table 4 PFP pharmacokinetic parameters in expired air by gender

From: Pharmacokinetics and pharmacodynamics of perfluoropropane after intra-venous bolus injection of perflutren lipid microsphere injection (DEFINITY®) in healthy Chinese volunteers

Pharmacokinetic parameters

Gender

n

Arithmetic mean (standard deviation)

Arithmetic coefficient of variation (%)

Median

Minimum value-Maximum value

Geometric mean

Geometric coefficient of variation (%)

Ae0 − 5 (uL)

Male

8

23.690 (13.448)

56.8

19.397

8.932–48.388

20.601

61.9

Female

4

43.984 (22.131)

50.3

49.278

13.711–63.669

37.941

79.7

Ae0 − 15.5 (uL)

Male

8

33.715 (19.543)

58

28.893

13.887–63.435

29.171

62.7

Female

4

58.692 (27.906)

47.5

65.828

19.549–83.565

51.457

73.9

Ae0 − tlast (uL)

Male

7

18.883 (11.045)

58.5

15.564

7.607–36.744

16.29

64.4

Female

4

35.812 (16.958)

47.4

40.083

12.163–50.920

31.488

72.6

Ae(uL)

Male

8

36.156 (20.445)

56.5

30.631

15.401–67.628

31.556

60.1

Female

4

62.680 (29.664)

47.3

69.417

21.385–90.499

55.161

72.2

CLlung (L/hr)

Male

8

2583.1 (2137.52)

82.7

1856

982–7318

2037.9

79.7

Female

4

4445.3 (2741.71)

61.7

4122

1559–7978

3769.1

78.6

PFP excretion rate1 (%)

Male

8

34.74 (18.641)

53.7

30.55

15.1–65.3

30.6

58.5

Female

4

74.20 (34.942)

47.1

83.7

25.7–103.7

65.43

71.4

PFP excretion rate2 (%)

Male

8

46.75 (25.088)

53.7

41.1

20.4–87.9

41.18

58.5

Female

4

99.85 (47.006)

47.1

112.65

34.6–139.5

88.05

71.3

PFP excretion rate3(%)

Male

8

27.79 (14.927)

53.7

24.4

12.1–52.3

24.47

58.5

Female

4

59.40 (27.950)

47.1

67.0

20.6–83.0

52.39

71.3